Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
PCVX
#847
Vaxcyte, Inc. Common Stock
61.740
0
+3.31%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+3.31%
Aylık değişim
+13.62%
6 aylık değişim
+45.96%
Yıllık değişim
+45.96%
Önceki kapanış
59.760
0
Open
61.740
0
Bid
Ask
Low
61.740
0
High
61.740
0
Hacim
145
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
PCVX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
124.64 M
128.76 M
129 M
129.82 M
130.91 M
143.92 M
—
Valuation ratios
Enterprise value
13.19 B
10.15 B
4.52 B
3.91 B
4.43 B
6.47 B
19.34 B
Price to earnings ratio
-24.79
-21.54
-9.46
-7.91
-7.44
-8.2
-33.01
Price to sales ratio
1 113.08
—
—
—
—
—
—
Price to cash flow ratio
26.72
22.06
10.3
9.24
8.83
9.58
37.94
Price to book ratio
1.52
3.02
0.4
0.32
0.38
2.34
3.44
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.03
0.04
0.04
0.05
0.07
0.08
0.24
Return on equity %
0.03
0.04
0.04
0.05
0.07
0.09
0.26
Return on invested capital %
53.9
—
41.35
53.35
60.38
72.9
227.97
Gross margin %
100
—
—
—
—
—
—
Operating margin %
1 655.91
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
1 220.4
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
17.88
12.75
17.7
11.11
8.83
7.91
45.55
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.49
0.91
1.23
0.89
1.05
1.65
4.82
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
17.63
14.32
12.32
12.21
12.57
11.47
48.57
Net current asset value per share
17.9
14.66
12.65
12.61
12.98
11.96
50.2
Tangible book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Working capital per share
16.9
13.51
11.94
11.48
11.51
10.45
45.37
Book value per share
27.63
27.1
23.58
22.58
21.24
19.73
87.13
Haberler
BTIG, Vaxcyte için hedef fiyatı aşı avantajıyla 89 dolara yükseltti
BTIG raises Vaxcyte price target to $89 on vaccine breadth edge
Leerink, Vaxcyte’ın hisse hedefini aşı hattı genişlemesi ile yükseltti
Leerink raises Vaxcyte stock price target on vaccine pipeline expansion
Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript
Ovintiv to Report Q4 Earnings: What's in Store for the Stock?
Vaxcyte closes $632.5 million public offering of common stock
Vaxcyte 550 milyon dolarlık halka arz fiyatlandırmasını tamamladı
Vaxcyte prices $550 million public offering of common stock
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
Vaxcyte launches $500 million public offering of common stock
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)